FDA Begins ‘Soft’ TAP, Will Phase In Pilot Over Five Years

An initiative from the Food and Drug Administration aimed at quickening the pace of bringing innovative medical devices to market and getting them to patients in need is under way. On 1 January, the agency launched the Total Product Lifecycle Advisory Program (TAP), which was one of the commitments agreed to between the FDA and industry as part of the Medical Device User Fee Amendments (MDUFA V).